- Q1. What is the business of Integris Medtech Limited?Integris Medtech is a medical-technology company that has diverse develops, manufactures and sells cardiovascular devices like stents, balloons, vascular access tools and laboratory solutions.
- Q2. Why is the company raising funds via IPO?The proceeds from the IPO will be used mainly to repay certain borrowings taken by its wholly-owned and step-down subsidiaries, and for general corporate purposes.
- Q3. What is the size of the issue and where will it list?The issue size comprises a fresh issue of ₹ 925 crore and OFS of ~ 2.167 crore equity shares, to be listed on the BSE NSE platform.
- Q4. What are the risks to an investor?Risks include regulatory and compliance requirements for medical-device firms, global competition in MedTech, execution/integration risks.
- Q5. What are the potential upsides?Potential upsides include growth in global and domestic healthcare demand, diversified product portfolio (cardio + lab), improving profitability (recent turnaround), and using IPO funds to reduce debt which strengthens financials and growth potential.
- Q6. How to apply for the IPO?You can apply Via your brokerage/demat account (or bank’s IPO/ASBA platform) once the subscription window opens.
Upcoming
Integris Medtech Limited IPO
0
Rating
Integris Medtech Limited is a diversified medical-technology (MedTech) company engaged in the development, manufacturing, and distribution of cardiovascular devices and laboratory solutions. The company provides products such as drug-eluting stents, diagnostic equipment, laboratory instruments, reagents, and consumables to hospitals and laboratories across India and global markets.
Integris Medtech Limited was incorporated on 25 April 2008.The current CEO of Integris Medtech Limited is Probir Das.
The core offerings include cardiovascular devices (like drug-eluting stents, drug-coated balloons, vascular-access solutions) and laboratory solutions (clinical diagnostics, life-science & industrial labs equipment/consumables, calibration services).It is a service based company and claimed to serve over 9,500 laboratories and more than 2,000 hospitals / cath-labs worldwide; in the drug-eluting stent segment it holds an estimated 22% market share in India.
Subscription date to apply for Integris Medtech Limited starts and closes on TBA. Price band for the IPO is TBA.
Revenue, PAT, EBITDA
|
Year
|
2025
|
|---|---|
|
Networth
|
~ ₹ 2752.52 Cr
|
|
Revenue
|
~ ₹ 1902.46 Cr
|
|
EBITDA
|
~ ₹ 309.39 Cr
|
|
PAT
|
~ ₹ 70.68 Cr
|
|
EBITDA Margin
|
~16.26%
|
|
PAT Margin
|
~3.72%
|
|
Face Value
|
Rs.01 per Equity Share
|
IPO Important Dates
|
#
|
Date
|
|---|---|
|
Open Date
|
TBA
|
|
Close Date
|
TBA
|
|
Anchor Investor Bidding
|
TBA
|
|
Allotment Date
|
TBA
|
|
Refunds& Demat Credit
|
TBA
|
|
Tentative Listing Date
|
TBA
|
Use Of Proceeds
|
Purpose
|
Amount
|
|---|---|
|
Borrowing payment
|
~ ₹ 696.39 Cr
|
|
wholly-owned Subsidiaries
|
~ ₹ 125.39 Cr
|
|
step-down Subsidiaries
|
~ ₹ 570.99 Cr
|
|
-
|
-
|
|
-
|
-
|
|
General Corporate Purpose
|
Balance
|
Financial Data
|
#
|
2023
|
2024
|
2025
|
|---|---|---|---|
|
Revenue (₹ Cr)
|
₹ 1,348.1
|
₹ 1,553.4
|
₹ 1,902.5
|
|
PAT (₹ Cr)
|
₹ -40.5
|
₹ -4.9
|
₹ 70.7
|
|
Asset (₹ Cr)
|
₹ 2,553.9
|
₹ 2,989.2
|
₹ 3,641.3
|
|
Net Worth (₹ Cr)
|
₹ 2,629.5
|
₹ 2,681.0
|
₹ 2,752.5
|
IPO Grey Market Premium
|
Date
|
IPO Price
|
IPO GMP
|
Profit Per Lot
|
|---|---|---|---|
|
17-Jun
|
₹ –
|
₹ –
|
₹ –
|
|
16-Jun
|
₹ –
|
₹ –
|
₹ –
|
|
15-Jun
|
₹ –
|
₹ –
|
₹ –
|
|
14-Jun
|
₹ –
|
₹ –
|
₹ –
|
|
13-Jun
|
₹ –
|
₹ –
|
₹ –
|
Promoters – Pre offer equity (Approx)
|
Promoters
|
% Shares
|
|---|---|
|
Evercure Holdings Pte. Ltd
|
-
|
|
Medicore Holdings Pte. Ltd
|
-
|
|
Gurmit Singh Chugh
|
-
|
|
Punita Sharma
|
-
|
|
-
|
-
|
|
-
|
-
|
Lot Size details
|
Application Type
|
Lot Size
|
No. of Lot
|
No. of Shares
|
Investment Amount
|
|---|---|---|---|---|
|
Retail (Min)
|
–
|
1
|
–
|
₹ –
|
|
Retail (Max)
|
–
|
13
|
–
|
₹ –
|
|
HNI (Min)
|
–
|
14
|
–
|
₹ –
|
|
HNI (Max)
|
–
|
66
|
–
|
₹ –
|
|
Big HNI (Min)
|
–
|
67
|
–
|
₹ –
|
Key Performance Index (KPI)
|
ROE
|
00
|
|---|---|
|
ROCE
|
00
|
|
RoNW
|
00
|
